Associated Scientists to Help Minimize Allergies Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2002
NCT00214552
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

fluticasone (cutivate) (1 trial)

Drugs in Phase 3 Trials (1)

rabeprazole (pariet) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Gastroesophageal Reflux (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2